3

FORM 3 SUBMISSION

Company: Dianthus Therapeutics, Inc. /DE/
Filed: June 20, 2018
Period of Report: June 20, 2018
Accession Number: 0000899243-18-017523

View Document ↗ View on SEC.gov ↗